Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/14935
Full metadata record
DC FieldValueLanguage
dc.contributor.authorcorda, G-
dc.date.accessioned2017-07-18T14:09:46Z-
dc.date.available2017-07-18T14:09:46Z-
dc.date.issued2017-
dc.identifier.citationOncogenesisen_US
dc.identifier.issn2157-9024-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/14935-
dc.description.abstractFrizzled receptors are the mediators of the wnt canonical and non-canonical pathways, which play fundamental roles in cell differentiation and organism development. A large body of work indicates that dysregulation of wnt signalling is a feature of oncogenic transformation, but most of the studies published so far focus on the assessment of the consequences of aberrations of the canonical pathway in human cancer. In this review, we discuss the emerging role of the wnt non-canonical pathway regulated by frizzled receptor 6 (Fzd6) in the pathogenesis of different types of human malignancies. The function played by Fzd6 in the physiology of normal and cancer cells has been highlighted in the view that an increased knowledge of the signalling pathways upstream and downstream of this receptor could ultimately result in the identification of new targets for cancer therapy.en_US
dc.language.isoenen_US
dc.publisherOncogenesisen_US
dc.titleNon-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage.en_US
dc.typeArticleen_US
dc.relation.isPartOfOncogenesis-
pubs.publication-statusAccepted-
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf2.23 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.